[RCUS] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[RCUS] Arcus Biosciences, Inc.
Announcement Date
02-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 5.98%
YoY- 22.49%
Quarter Report
RCUS's Result
RCUS's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 29,000 25,000 345 33,581 26,759 18,005 354,499 -81.24%
PBT -74,000 -78,000 -67,000 -64,919 -66,632 -66,989 281,183 -
Tax 1,000 2,000 -4 -4,478 -2,350 1,004 1,815 -32.86%
NP -75,000 -80,000 -66,996 -60,441 -64,282 -67,993 279,368 -
Tax Rate - - - - - - -0.65% -
Total Cost 104,000 105,000 67,341 94,022 91,041 85,998 75,131 24.28%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -258.62 -320.00 -19,419.13 -179.99 -240.23 -377.63 78.81 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -1.02 -1.10 -0.92 -0.84 -0.90 -0.96 3.97 -
EPS Diluted -1.02 -1.10 -0.92 -0.84 -0.90 -0.96 3.71 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.